Speciality: Emergency Medicine
Description:
A warm welcome to all the medical professionals in this interesting session on the potential benefits of intravenous glutamine therapy.
Intravenous (IV) glutamine therapy has garnered attention for its potential therapeutic benefits in various clinical settings. Glutamine, an amino acid, plays a crucial role in numerous physiological processes, including protein synthesis, immune function, and cellular metabolism.
IV administration of glutamine bypasses the digestive system, allowing for rapid absorption and delivery of this essential nutrient directly into the bloodstream. This method is particularly beneficial for patients with conditions such as critical illness, sepsis, and intestinal failure, where oral intake may be compromised or insufficient. IV glutamine supplementation aims to replenish depleted glutamine stores, support immune function, and promote tissue repair and recovery in critically ill patients.
The use of IV glutamine therapy extends beyond critical care settings, with emerging evidence suggesting potential benefits in other clinical scenarios. For example, IV glutamine has shown promise in reducing chemotherapy-induced mucositis and improving outcomes in patients undergoing bone marrow transplantation.
Therefore, get an overall knowledge on the understanding of the potential benefits of intravenous glutamine therapy. Listen to the webinar, grab the shared knowledge, and follow Hidoc for more such interesting webinar sessions.
See More Webinars @ Hidoc Webinars
See More Webinars @ Hidoc Webinars
1.
Why preventive mastectomy isn't offered to everyone at risk
2.
Financial hardship common in patients with cancer
3.
Academics + Pharma = Big Bucks; New CAR-T Warnings; Patients Seek Cancer Tests.
4.
Acalabrutinib + Venetoclax Combo Earns FDA Nod for CLL
5.
Severe obesity associated with reduced prevalence of recommended cancer screenings
1.
Sound Waves and Self-Destruction: A Promising Nanotech Weapon in the Fight Against Cancer
2.
Claudin-18.2 in Gastric Cancer: Tumor-Stroma Crosstalk and Disease Progression
3.
Real-World Oncology Insights: CAR-T, Immunotherapy, PROs, and Digital Tools
4.
Unleashing Precision Medicine: CRISPR-Cas9 Gene Editing in Hematopoietic Stem Cells
5.
Unveiling Tumor Immunity: Pan-Cancer Proteogenomics Characterization
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Current Scenario of Blood Cancer- Genomic Testing & Advancement in Diagnosis and Treatment
2.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part V
3.
From Relapse to Remission Mapping the Treatment Journey in Adult R R B Cell ALL The Critical Goal of MRD
4.
Redefining Treatment Pathways in Relapsed/Refractory Adult B-Cell ALL
5.
Managing ALK+ NSCLC while Ensuring Long-Term Safety of the Patients
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation